Injunction
发表于 2025-3-25 05:47:35
Book 2011studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications wer
fidelity
发表于 2025-3-25 10:03:42
http://reply.papertrans.cn/19/1889/188886/188886_22.png
CRAFT
发表于 2025-3-25 12:31:57
http://reply.papertrans.cn/19/1889/188886/188886_23.png
Intend
发表于 2025-3-25 18:37:07
http://reply.papertrans.cn/19/1889/188886/188886_24.png
ROOF
发表于 2025-3-25 23:21:52
http://reply.papertrans.cn/19/1889/188886/188886_25.png
sperse
发表于 2025-3-26 03:23:18
http://reply.papertrans.cn/19/1889/188886/188886_26.png
Anticlimax
发表于 2025-3-26 04:25:12
http://reply.papertrans.cn/19/1889/188886/188886_27.png
BALE
发表于 2025-3-26 08:59:13
http://reply.papertrans.cn/19/1889/188886/188886_28.png
感激小女
发表于 2025-3-26 15:45:07
http://reply.papertrans.cn/19/1889/188886/188886_29.png
舰旗
发表于 2025-3-26 17:32:17
http://reply.papertrans.cn/19/1889/188886/188886_30.png